Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantitative Polypharmacology Profiling Based on a Multifingerprint Similarity Predictive Approach
Fulvio Ciriaco, Nicola Gambacorta, Domenico Alberga, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 10, pp. 4868-4876
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

PLATO: A Predictive Drug Discovery Web Platform for Efficient Target Fishing and Bioactivity Profiling of Small Molecules
Fulvio Ciriaco, Nicola Gambacorta, Daniela Trisciuzzi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5245-5245
Open Access | Times Cited: 48
TISBE: A Public Web Platform for the Consensus-Based Explainable Prediction of Developmental Toxicity
Fabrizio Mastrolorito, Maria Vittoria Togo, Nicola Gambacorta, et al.
Chemical Research in Toxicology (2024) Vol. 37, Iss. 2, pp. 323-339
Closed Access | Times Cited: 14
Retrospective Clinical Investigation into the Association Between Abnormal Blood Clotting, Oral Anticoagulant Therapy, and Medium-Term Mortality in a Cohort of COVID-19 Patients
Giorgia Dinoi, Maria Vittoria Togo, Pietro Guida, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 535-535
Open Access | Times Cited: 1
TIRESIA: An eXplainable Artificial Intelligence Platform for Predicting Developmental Toxicity
Maria Vittoria Togo, Fabrizio Mastrolorito, Fulvio Ciriaco, et al.
Journal of Chemical Information and Modeling (2022) Vol. 63, Iss. 1, pp. 56-66
Closed Access | Times Cited: 31
CIRCE: Web-Based Platform for the Prediction of Cannabinoid Receptor Ligands Using Explainable Machine Learning
Nicola Gambacorta, Fulvio Ciriaco, Nicola Amoroso, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 18, pp. 5916-5926
Closed Access | Times Cited: 22
An Integrated Machine Learning Model To Spot Peptide Binding Pockets in 3D Protein Screening
Daniela Trisciuzzi, Lydia Siragusa, Massimo Baroni, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 24, pp. 6812-6824
Closed Access | Times Cited: 21
Fifteen years of ChEMBL and its role in cheminformatics and drug discovery
Barbara Zdrazil
Journal of Cheminformatics (2025) Vol. 17, Iss. 1
Open Access
MolPredictX: Online Biological Activity Predictions by Machine Learning Models
Marcus Tullius Scotti, Chonny Herrera‐Acevedo, Renata Priscila Barros de Menezes, et al.
Molecular Informatics (2022) Vol. 41, Iss. 12
Closed Access | Times Cited: 18
Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
Valeria Gasperi, Tatiana Guzzo, Alessandra Topai, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 12, pp. 1420-1457
Closed Access | Times Cited: 18
CUPID: a free drug discovery platform for the explainable multi-ion channel assessment of cardiotoxicity
Nicola Gambacorta, Fabrizio Mastrolorito, Maria Vittoria Togo, et al.
European Journal of Medicinal Chemistry (2025), pp. 117575-117575
Closed Access
PoseidonQ: A Free Machine Learning Platform for the Development, Analysis, and Validation of Efficient and Portable QSAR Models for Drug Discovery
Muzammil Kabier, Nicola Gambacorta, Fulvio Ciriaco, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Rational Discovery of Antiviral Whey Protein-Derived Small Peptides Targeting the SARS-CoV-2 Main Protease
Nicola Gambacorta, Leonardo Caputo, Laura Quintieri, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1067-1067
Open Access | Times Cited: 13
Synthesis of Novel Benzo[b][1,6]naphthyridine Derivatives and Investigation of Their Potential as Scaffolds of MAO Inhibitors
Л. Н. Куликова, Ghulam Reza Raesi, D.D. Levickaya, et al.
Molecules (2023) Vol. 28, Iss. 4, pp. 1662-1662
Open Access | Times Cited: 6
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure–Activity Relationship Studies and Target Prediction Analysis
Rosa Amoroso, Laura De Lellis, Rosalba Florio, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 937-937
Open Access | Times Cited: 8
Towards Alzheimer’s disease-related targets: One-pot Cu(I)- mediated synthesis of new nitroindazolyltriazoles
Mohammed Eddahmi, Gabriella La Spada, Abderrafia Hafid, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106261-106261
Closed Access | Times Cited: 8
Design of new Mcl-1 inhibitors for cancer using fragments hybridization, molecular docking, and molecular dynamics studies
Abdulrahim A. Alzain, Fatima A. Elbadwi, Rua M. Mukhtar, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-13
Closed Access | Times Cited: 4
From Deep Learning to the Discovery of Promising VEGFR‐2 Inhibitors
Mehmet Ali Yucel, Ercan Adal, Mine Buga Aktekin, et al.
ChemMedChem (2024) Vol. 19, Iss. 16
Open Access | Times Cited: 1
Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity
Antonio Lopalco, Rosa Maria Iacobazzi, Angela Lopedota, et al.
Methods in molecular biology (2024), pp. 303-332
Closed Access | Times Cited: 1
Investigating the Benefit-Risk Profile of Drugs: From Spontaneous Reporting Systems to Real-World Data for Pharmacovigilance
Paola Imbrici, Michela De Bellis, Antonella Liantonio, et al.
Methods in molecular biology (2024), pp. 333-349
Closed Access | Times Cited: 1
In Vitro Cell-Based MTT and Crystal Violet Assays for Drug Toxicity Screening
Alessandra Gambacurta, Valentina Tullio, Isabella Savini, et al.
Methods in molecular biology (2024), pp. 293-301
Closed Access | Times Cited: 1
Artificial intelligence-driven identification of morin analogues acting as CaV1.2 channel blockers: Synthesis and biological evaluation
Gabriele Carullo, Federica Falbo, Amer Ahmed, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106326-106326
Closed Access | Times Cited: 7
TIRESIA and TISBE: Explainable Artificial Intelligence Based Web Platforms for the Transparent Assessment of the Developmental Toxicity of Chemicals and Drugs
Maria Vittoria Togo, Fabrizio Mastrolorito, Nicola Gambacorta, et al.
Methods in molecular biology (2024), pp. 373-391
Closed Access | Times Cited: 1
How do we further enhance 2D fingerprint similarity searching for novel drug discovery?
Ingo Muegge, Yuan Hu
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 11, pp. 1173-1176
Closed Access | Times Cited: 5
Turbo prediction: a new approach for bioactivity prediction
Ammar Abdo, Maude Pupin
Journal of Computer-Aided Molecular Design (2022) Vol. 36, Iss. 1, pp. 77-85
Closed Access | Times Cited: 3
Virtual Reverse Screening Approach to Target Type 2 Cannabinoid Receptor
Fulvio Ciriaco, Nicola Gambacorta, Francesco Leonetti, et al.
Methods in molecular biology (2022), pp. 495-504
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top